Ticker
CSTLCompany Name
CASTLE BIOSCIENCES INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 544.73M | $ 82.23M | 15.1% |
3/31/2025 | $ 501.71M | $ 89.69M | 17.88% |
12/31/2024 | $ 531.24M | $ 119.71M | 22.53% |
9/30/2024 | $ 514.57M | $ 94.96M | 18.45% |
6/30/2024 | $ 487.31M | $ 85.57M | 17.56% |
3/31/2024 | $ 458.51M | $ 82.95M | 18.09% |
12/31/2023 | $ 453.34M | $ 98.84M | 21.8% |
9/30/2023 | $ 436.02M | $ 91.22M | 20.92% |
6/30/2023 | $ 425.4M | $ 95.87M | 22.54% |
3/31/2023 | $ 426.89M | $ 114.82M | 26.9% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for CASTLE BIOSCIENCES INC is calculated as follows: CashnEq [ $ 183.05M ] / Assets [ $ 210.39M ]
(=) Cash to Assets [ 87% ]
Minimum
Jun 30, 2025
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.95K |
---|---|
min | 0% |
max | 40.89% |
average | 9.83% |
median | 6.45% |
std | 9.61% |